Dr. Ana Robles, National Cancer Institute, NIH, explains how her team used formalin-fixed paraffin embedded samples, routinely collected from lung cancer patients, to determine the staging of lung cancers using droplet digital PCR. She goes on to share how developing biomarkers for lung cancer progression can help clinical management of patients after surgery.